Nice_老虎社区_美港股上老虎

MattTanKL
2021-09-07

Nice

Shares Of Abbott Laboratories (ABT) Rise Above Previous 52-Week High

Abbott Laboratories (NYSE: ABT) traded today at a new 52-week high of $129.40.

Shares Of Abbott Laboratories (ABT) Rise Above Previous 52-Week High

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":880141883,"tweetId":"880141883","gmtCreate":1631027227542,"gmtModify":1631888778761,"author":{"id":3559907327014688,"authorId":3559907327014688,"authorIdStr":"3559907327014688","name":"MattTanKL","avatar":"https://static.tigerbbs.com/fc162178d38b1ea41df0b204554ad865","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Nice</p></body></html>","htmlText":"<html><head></head><body><p>Nice</p></body></html>","text":"Nice","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/880141883","repostId":2165354603,"repostType":2,"repost":{"id":"2165354603","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1631026877,"share":"https://www.laohu8.com/m/news/2165354603?lang=&edition=full","pubTime":"2021-09-07 23:01","market":"us","language":"en","title":"Shares Of Abbott Laboratories (ABT) Rise Above Previous 52-Week High","url":"https://stock-news.laohu8.com/highlight/detail?id=2165354603","media":"Benzinga","summary":"Abbott Laboratories (NYSE: ABT) traded today at a new 52-week high of $129.40.","content":"<html><body><p><strong>Abbott Laboratories</strong> (NYSE:ABT) traded today at a new 52-week high of $129.40. Approximately 642,000 shares have changed hands today, as compared to an average 30-day volume of 4.1 million shares.</p>\n<p>Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays, and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.</p>\n<p><strong>Abbott Laboratories</strong> (NYSE:ABT) is currently priced 30.4% above its average consensus analyst price target of $89.75.</p>\n<p>Over the past year, Abbott Laboratories has traded in a range of $100.34 to $129.40 and is now at $128.88, 28% above that low.</p>\n<p><strong>Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts</strong>\r\nTo stay connected with our complimentary <strong>IBN Spotlights</strong>, please visit https://IBN.fm/connected</p>\n<p><strong>About InvestorBrandNetwork (IBN)</strong>\r\nInvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.</p>\n<p>For more information, please visit https://www.InvestorBrandNetwork.com</p>\n<p>Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer</p>\r\nImage by Photo Mix from Pixabay </body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shares Of Abbott Laboratories (ABT) Rise Above Previous 52-Week High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShares Of Abbott Laboratories (ABT) Rise Above Previous 52-Week High\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-07 23:01</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>Abbott Laboratories</strong> (NYSE:ABT) traded today at a new 52-week high of $129.40. Approximately 642,000 shares have changed hands today, as compared to an average 30-day volume of 4.1 million shares.</p>\n<p>Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays, and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.</p>\n<p><strong>Abbott Laboratories</strong> (NYSE:ABT) is currently priced 30.4% above its average consensus analyst price target of $89.75.</p>\n<p>Over the past year, Abbott Laboratories has traded in a range of $100.34 to $129.40 and is now at $128.88, 28% above that low.</p>\n<p><strong>Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts</strong>\r\nTo stay connected with our complimentary <strong>IBN Spotlights</strong>, please visit https://IBN.fm/connected</p>\n<p><strong>About InvestorBrandNetwork (IBN)</strong>\r\nInvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.</p>\n<p>For more information, please visit https://www.InvestorBrandNetwork.com</p>\n<p>Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer</p>\r\nImage by Photo Mix from Pixabay </body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABT":"雅培"},"source_url":"https://www.benzinga.com/news/earnings/21/09/22829194/shares-of-abbott-laboratories-abt-rise-above-previous-52-week-high","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2165354603","content_text":"Abbott Laboratories (NYSE:ABT) traded today at a new 52-week high of $129.40. Approximately 642,000 shares have changed hands today, as compared to an average 30-day volume of 4.1 million shares.\nAbbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays, and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.\nAbbott Laboratories (NYSE:ABT) is currently priced 30.4% above its average consensus analyst price target of $89.75.\nOver the past year, Abbott Laboratories has traded in a range of $100.34 to $129.40 and is now at $128.88, 28% above that low.\nReceive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts\r\nTo stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected\nAbout InvestorBrandNetwork (IBN)\r\nInvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.\nFor more information, please visit https://www.InvestorBrandNetwork.com\nPlease see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer\r\nImage by Photo Mix from Pixabay","news_type":1},"isVote":1,"tweetType":1,"viewCount":86,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}